NCT07417592

Brief Summary

The goal of this observational study is to learn about the priorities of patients admitted to intensive care units (ICUs) who have a life-threatening condition, as well as the priorities assumed by their designated relatives and healthcare professionals (nurses, nursing assistants, ICU physicians, and general practitioners).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
17mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Feb 2026Nov 2027

First Submitted

Initial submission to the registry

February 11, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

February 15, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2027

Last Updated

March 5, 2026

Status Verified

January 1, 2026

Enrollment Period

1.5 years

First QC Date

February 11, 2026

Last Update Submit

March 3, 2026

Conditions

Intensive Care Unit Syndrome

Outcome Measures

Primary Outcomes (1)

  • Agreement rate

    Assessment of the consistency between the priorities of patients and/or those assumed by the referring person and the priorities assumed by caregivers (resuscitation team and attending physician, if possible).

    48 hours

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient admitted to intensive care Contact person for patients admitted to intensive care Caregiver for patients admitted to intensive care Family doctor for patients admitted to intensive care

You may qualify if:

  • Adult Patient
  • Estimated length of stay in intensive care exceeding 72 hours
  • No objection from the patient or the designated representative, if the patient is unable to consent to participate in the study
  • Adult Person
  • No objection to participate in the study
  • No objection to participate in the study

You may not qualify if:

  • Patients under legal protection (guardianship, conservatorship)
  • Pregnant or breastfeeding women
  • Disagreement among the patient's relatives regarding the designated representative.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Brest

Brest, 29200, France

Location

Central Study Contacts

Thomas GARGADENNEC, MD

CONTACT

02 30 33 78 94thomas.gargadennec@chu-brest.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2026

First Posted

February 18, 2026

Study Start

February 15, 2026

Primary Completion (Estimated)

August 15, 2027

Study Completion (Estimated)

November 14, 2027

Last Updated

March 5, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning five years and ending fifteen years following the final study report completion
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

Locations

FR(1)